Corticosteroids Augment BRAF Inhibitor Vemurafenib Induced Lymphopenia and Risk of Infection

Wiebke Sondermann; Klaus G. Griewank; Bastian Schilling; Elisabeth Livingstone; Julia C. Leyh; Natalia Rompoti; Ioana Cosgarea; Tobias Schimming; Dirk Schadendorf; Lisa Zimmer; Uwe Hillen

doi:10.1371/journal.pone.0124590

Loading metrics

Open Access

Peer-reviewed

Research Article

Corticosteroids Augment BRAF Inhibitor Vemurafenib Induced Lymphopenia and Risk of Infection

Wiebke Sondermann,

Affiliation Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany
⨯
Klaus G. Griewank ,

* E-mail: klaus.griewank@uk-essen.de (KGG); uwe.hillen@uk-essen.de (UH)

Affiliation Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany
⨯
Bastian Schilling,

Affiliation Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany
⨯
Elisabeth Livingstone,

Affiliation Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany
⨯
Julia C. Leyh,

Affiliation Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany
⨯
Natalia Rompoti,

Affiliation Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany
⨯
Ioana Cosgarea,

Affiliation Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany
⨯
Tobias Schimming,

Affiliation Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany
⨯
Dirk Schadendorf,

Affiliation Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany
⨯
Lisa Zimmer,

Affiliation Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany
⨯
Uwe Hillen

* E-mail: klaus.griewank@uk-essen.de (KGG); uwe.hillen@uk-essen.de (UH)

Affiliation Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany
⨯

Corticosteroids Augment BRAF Inhibitor Vemurafenib Induced Lymphopenia and Risk of Infection

Wiebke Sondermann,
Klaus G. Griewank,
Bastian Schilling,
Elisabeth Livingstone,
Julia C. Leyh,
Natalia Rompoti,
Ioana Cosgarea,
Tobias Schimming,
Dirk Schadendorf,
Lisa Zimmer

Published: April 21, 2015
https://doi.org/10.1371/journal.pone.0124590

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Lymphocytes
Is the Subject Area "Lymphocytes" applicable to this article?

Thanks for your feedback.
Lymphopenia
Is the Subject Area "Lymphopenia" applicable to this article?

Thanks for your feedback.
Corticosteroid therapy
Is the Subject Area "Corticosteroid therapy" applicable to this article?

Thanks for your feedback.
Cancer immunotherapy
Is the Subject Area "Cancer immunotherapy" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Eosinophils
Is the Subject Area "Eosinophils" applicable to this article?

Thanks for your feedback.
Neutrophils
Is the Subject Area "Neutrophils" applicable to this article?

Thanks for your feedback.
Metastasis
Is the Subject Area "Metastasis" applicable to this article?

Thanks for your feedback.